Abstract. Transgenic mice overexpressing the human amyloid precursor protein (APPV717F) develop cerebral amyloid angiopathy (CAA) as they age. We have examined the effect of CAA on blood vessels in vivo using multiphoton laser scanning microscopy. We are able to simultaneously detect, in an alive but anesthetized animal, fluorescent angiography of microvessels as well as the presence of amyloid angiopathy in 3-dimensional volumes near the surface of the brain. Analysis revealed dilation of the portions of vessels that were associated with amyloid deposition, even when that amyloid deposition was quite mild. In addition, analysis of the 3-dimensional reconstruction of the relationship between the vasculature and CAA suggest that CAA is initiated close to branch points of vessels. Taken together, these data suggest that CAA has a substantial effect on the physiology of the microvasculature in vivo.
INTRODUCTION
Congophilic amyloid angiopathy (CAA), the accumulation of Aß fibrils in the media of cerebral blood vessels, is a common concomitant of Alzheimer disease (1, 2) . In addition, CAA can occur independently of significant Alzheimer-type pathology and has been shown to be a major cause of lobar intracerebral hemorrhage-type stroke in the elderly (3, 4) . The natural history and physiological consequences of Aß deposition in blood vessels has been difficult to discern because the affected vessels are too small to see angiographically, forcing most studies to rely on postmortem analyses.
We have taken advantage of the fact that some transgenic mouse models of Alzheimer disease that overexpress mutant forms of the amyloid precursor protein (APP) also develop Aß deposits in the cerebral vascular (5) (6) (7) (8) (9) . For example, the PDAPP mice used here (5) overexpress APPV717F using a platelet-derived growth factor B-chain promoter. Aged mice homozygous for this transgene develop, in addition to the Aß deposits in the neuropil observed in younger heterozygous mice, striking CAA that is histologically similar to CAA seen in human disease.
In the current study we ask what the physiologic consequences of CAA are on the resting blood vessel. We use in vivo multiphoton microscopy to simultaneously visualize thioflavine-S-positive amyloid deposits in vessel walls and blood flow within vessels in anesthetized, living animals. Multiphoton microscopy is a new technique (10) that uses long wavelength light to excite standard fluorophors within a very small volume. As this focal volume is rapidly scanned across a field, extremely high-resolution optical sections can be obtained. 
MATERIALS AND METHODS

Animals
10 homozygote PDAPP mice (aged 15-21 months, all female) were used for the in vivo imaging of CAA. These mice overexpress mutant human amyloid precursor protein (APPV717F). The PDAPP transgenic mice were bred from the previously established line PDAPP-109 over several generations on hybrid backgrounds representing combinations of C57BL/6, DBA, and Swiss-Webster strains, as previously described by Games et al in 1995 (5) .
Preparatory Surgery
Mice were anesthetized with Avertin (Tribromoethanol, 250 mg/kg IP). A small craniotomy (about 1 mm in diameter) was carefully created using a high-speed drill (Fine Science Tools, Foster City, CA) under a dissecting microscope (Leica). The site was moistened with artificial cerebrospinal fluid (ACSF; 125 mM NaCl; 26 mM NaHCO 3 ; 1.25 mM NaH 2 PO 4 ; 2.5 mM KCl; 1 mM MgCl 2 ; 1 mM CaCl 2 ; 25 mM glucose) and the dura gently peeled away from the surface of the brain.
Imaging Agents
Thioflavine S (0.005% ThioS in ACSF, Sigma Chemical, St. Louis, MO) was topically applied to the site in order to label ThioS-positive amyloid deposits. Texas red labeled 70,000 MW dextran, which does not cross the blood-brain barrier (Molecular Probes, Eugene, CO), was intravenously injected into the tail vein of the mice in order to visualize the lumen of blood vessels and obtain a fluorescent angiogram. Both agents were applied 20 min prior to imaging. 
In Vivo Imaging
After 20 min, the topical application of ThioS was washed off with ACSF, and the animal was placed in a head holder on a small custom modified stage insert of an Olympus BX-50 microscope ( Fig. 1) , and the site imaged using a Biorad 1024 MP microscope (BioRad 1024MP, BioRad, Hercules, CA). Multiphoton fluorescence was generated with 750 nm excitation from a mode-locked Ti:Sapphire laser (Tsunami, Spectra Physics, Mountain View, CA; 10W Millenium pump laser, pulse 60-100fs). Custom-built external detectors (Hamamatsu Photonics, Bridgewater, NJ) collected emitted light in the range of 400-480 nm (ThioS), and 560-650 nm (Texas red). A series of optical sections (615 X 615 m) z-series using a 20x objective (Olympus, NA 0.6) was then collected. An incremental z-step of 5 m was used to generate a 3-dimensional stack of images from the skull surface to a depth of about 200 m into the brain.
Image Processing
Images were examined as a single stack of images using Scion Image (Scion Corp, Frederick, MD) and ImageTool (University of Texas Health Science Center, San Antonio, TX). Images were reconstructed in 3 dimensions in order to examine vascular structures via Texas Red angiograms and vessel associated ThioS amyloid deposits, then collapsed into an XY projection. Portions of angiograms that were technically inadequate (e.g. at the deepest optical planes) were excluded prior to analysis.
Quantitative Analysis of Images
In order to determine the effect of Aß on vessel diameter, we analyzed the widths of all vessels with clear angiograms and a detectable amount of amyloid angiopathy. The diameters of the internal lumen of these vessels were measured every 30 m along their length starting at a random point (i.e. systematic random sampling [11] ). At each point of measurement, the vessel segment was noted as either being affected or unaffected by Aß, and used a semiquantitative scale (0 ϭ none; ϩ ϭ mild; ϩϩ ϭ moderate; ϩϩϩ ϭ severe) to assess the extent of Aß deposition (Fig. 2) .
To test the hypothesis that Aß deposits tend to occur near branch points of vessels, we systematically sampled a selection of points in space, 100 m apart, overlayed on the images. For every point that overlapped a vessel, we noted whether that part of the vessel was affected or unaffected by Aß. We also measured the distance from this point to the nearest branch point on that vessel.
RESULTS
Concurrent Imaging of Aß and Microangiography
Thio S, which is a green fluorophor, and Texas red, a red fluorophor, can be detected simultaneously with available filter sets. Both fluoresce brightly with exposure to 750 nm excitation with a mode-locked Ti sapphire laser. A 3-dimensional stack of optical images, approximately 615 X 615 X 200-m-deep, was collapsed for further analysis. Figure 2 shows the vessel lumen in red, and the circumferential deposits of Aß that stain with Thio S in green. Because these are collapsed images, occasionally the red and green overlap in the images and appear yellow in the figure; in individual cross sections, the Thio S staining always surrounds the Texas red column and does not overlap.
To examine the effect of Aß on vessel physiology, we measured vessel diameter. It is clear that some vessels contain Aß in part of the vessel, but not in other parts. This discontinuity of Aß deposition is a hallmark of amyloid angiopathy clinically and is replicated in the transgenic model. Using a random start position, we measured diameter every 30 m along the vessel (Fig. 3) . This represents an adaptation of the stereologically based ''systematic random sampling'' approach. A semiquantitative score was assigned for each point. The vessel segments containing Aß amyloid were compared to vessel segments not containing amyloid in each vessel. Thus, the vessel serves as its own ''control.'' Using this analysis, we found that the portions of the vessel segments that contained Thio S-positive staining were approximately 16% larger than vessel segments without Aß (p Ͻ 0.001, paired t-test). Surprisingly, there was no clear indication that severity of vessel changes worsened this effect (Fig. 4) Fig. 2 . Examples of the co-occurrence of amyloid angiopathy and microvascular anatomy. We employed a semiquantitative rating scale (none, mild, moderate, severe) as illustrated in the figure. The red illustrates the Texas red-dextran conjugate in the blood vessels, and the green represents the Thioflavine-S amyloid angiopathy. Yellow is seen in some images because these are collapsed images from thick optical sections. There is a significant difference between amyloid-containing and non-amyloid-containing vessels for mild (n ϭ 11), moderate (n ϭ 10), and severe (n ϭ 6) vessels. * ϭ p Ͻ 0.01.
Fig. 5.
Example of mild amyloid angiopathy occurring near the branch points of vesssels. The method for measuring distance is illustrated with an overlay of random points from which the distance from the nearest branch point is measured. Fig. 6 . Distance of amyloid deposits from nearest branch point. Measurements were carried out as illustrated in Figure 5 and described in the text. The significant differences were seen in both mild (n ϭ 75 vessel segments, p Ͻ 0.005) and moderate (n ϭ 73 vessel segments, p Ͻ 0.005) vessels, with amyloid tending to occur near branch points. A smaller difference, not reaching statistical significance was seen in severely affected vessels (n ϭ 59).
amyloid angiopathy was just ''mild,'' the control vessel segment had an average internal diameter of 27.7 m, whereas the amyloid-containing vessel had an internal diameter of 32.1 m (p Ͻ 0.01). Of interest, the severely affected blood vessels had only slightly larger diameters, 30.8 m for non-amyloid-containing and 35.5 m for amyloid-containing segments (p Ͻ 0.005).
Our in vivo imaging also provided a unique 3-dimensional data set in which to examine the relationship of amyloid deposits around blood vessels with the architecture of the vasculature. In our initial imaging sessions, we were struck by the frequency with which amyloid deposits appeared to occur at or near branch points of vessels (Fig. 5) . To test this idea, we developed a random sampling method to evaluate the likelihood that amyloid deposits were, in fact, more likely to be close to branch points than not. We overlayed a sample grid with a probe located every 100 m over the images. If a probe happened to overlap a blood vessel, that vessel segment was rated as having (or not having) amyloid deposits, and the distance from that point on the vessel to the closest branch points was measured. Only vessels that contain some Aß were included in this analysis, because we were unable to ascertain with certainty whether vessels that did not contain amyloid were small arterioles or venules. We assumed that vessels with ''mild'' changes were most likely in the ''early'' phase of amyloid deposition, and that vessels with moderate-to-severe changes are in later stages. If so, we predicted that amyloid-containing segments in mild vessels would appear to be ''closer'' to branch points than those in moderate or severe cases if the amyloid deposition tended to start near a branch point and then ''fill in'' more and more of the vessel. Our data support this hypothesis. Among vessels affected by mild amounts of Aß, vessel segments that contained amyloid were significantly closer to vessel branches than unaffected vessel segments (62 Ϯ 10 m (mean Ϯ SE) for Aß-containing vessel segments versus 133 Ϯ 17 m for non-Aß-containing segments, p Ͻ 0.005, t-test) (Fig. 6) . closer to vessel branches than unaffected vessel segments, but the absolute distance to the branch point is increased compared to mildly affected vessels. The median distance was 84 Ϯ 10 m for Aß-containing vessels versus 148 Ϯ 21 m for non-Aß-containing vessels (p Ͻ 0.005). Interestingly, among the severely affected vessels where almost the entire length of the vessel wall was affected by amyloid angiopathy, the relationship between the presence of amyloid and relative closeness to a branch point was less evident (116 Ϯ 15 m vs 160 Ϯ 26 m, not significant).
DISCUSSION
In our current study we used a novel optical imaging technique, in vivo multiphoton microscopy, to examine the consequences of amyloid deposition on blood vessels in living transgenic mice. We describe several new observations: even mild degrees of cerebral amyloid angiopathy lead to an alteration in vessel anatomy in vivo, with a statistically significant dilation of the vessel; this appears to be the case in a graded fashion, with increasing amounts of amyloid there is increased vessel dilation. This result shows directly an impairment in vessel physiology in vessels affected by CAA. Because this effect is seen in mildly affected vessels, we do not think that it is due to the direct smooth muscle cell loss seen in advanced CAA in humans (1, 12) . Preliminary studies using phalloidin staining as a marker for smooth muscle cells shows that the density of smooth muscle cell in vessels containing mild amyloid angiopathy does not differ from vessels that are normal.
Moreover, preliminary studies in Tg2576 transgenic mice that also develop amyloid angiopathy suggest an impairment of pharmacologically induced dilation in vessels that contain CAA (Christie et al, unpublished data). Another mouse line that overexpresses human APP (Swedish mutation), on an FVB background, did not develop Aß deposits but did show impairments of endothelial-dependent changes in cerebral blood flow (13) . Aß peptide has also been described to have both toxic effects on endothelial cells, and smooth muscle cells (14, 15) as well as vasoactive properties (16) (17) (18) . Taken together with our results, these data strongly suggest that the deposition of Aß in microvessels causes an alteration in the integrity of microvascular responsiveness in vivo. It will be interesting to see if similar alterations are also observed in other transgenic mouse models that develop CAA (19, 20) .
Multiphoton microscopy also provided us with the opportunity to evaluate a fairly large 3-dimensional reconstruction of the cerebral vasculature at unprecedented levels of resolution. In the XY plane, the resolution of multiphoton microscope, as we have configured it, is approximately 1 m. Thus, we are able to detect in vivo fine capillary structures deep to the surface of the brain.
Quantitative evaluation of the reconstructions suggested that, in cases of mild amyloid angiopathy, the amyloid tended to occur near branch points of vessels. This is an intriguing observation, which would have been difficult to detect in histological cross-sections, and is reminiscent in some ways of the atherosclerotic process. This association suggests that unique vascular factors are likely important in initiating amyloid deposition, potentially including issues such as microturbulence within the vessel, or subtle changes in vessel morphology near branching structures. The extent to which amyloid is selectively near branch points diminishes with increasing severity of CAA, until this effect disappears in severe CAA. We anticipate that, using multiphoton microscopy over extended periods of observation (months), we may be able to ultimately follow the progression of amyloid deposits over time and evaluate the possibility that vascular remodeling occurs.
